What Is the Prognosis and Course of Folliculitis Decalvans?
At a Glance
Folliculitis decalvans has an unpredictable course of flares and quieter periods. Hair loss from follicles that have scarred is usually permanent, but early control of inflammation, regular monitoring, and prompt attention to flares can help protect hair follicles that have not scarred.
In this answer
3 sections
The progression of Quinquaud folliculitis decalvans (FD) varies widely from person to person, and there is no single timeline that applies to everyone [1]. FD is a chronic (long-lasting) condition characterized by alternating periods of active inflammation and periods of relative quiet, known as remission (a period without clinically active disease) [2].
Because the inflammation in FD can destroy hair follicles and replace them with scar tissue, the long-term outlook focuses on keeping the condition quiet to prevent further hair loss [2][3]. Hair loss from fully scarred follicles is usually permanent, and existing scarred patches generally do not recover their hair [4][2]. However, inflamed follicles that have not yet scarred can often be preserved or recover, making early and effective control of inflammation a key goal and an important influence on your prognosis [4][2].
Coping with Hair Loss
Experiencing permanent hair loss can be deeply distressing. Once the disease activity has been stable and quiet for a long period, you can discuss options like camouflage techniques, hairpieces, or whether reconstructive options (like hair transplantation) might be appropriate [2][5].
How the Condition Progresses
FD progresses through repeated cycles of inflammation [2]. During an active flare, you may notice pustules (pus-filled bumps), redness, crusting, and trichodynia (scalp tenderness, pain, or burning) [6]. These inflamed lesions can cause the scarred, hairless area to expand centrifugally (spreading outward from the center) over time [2][4].
The speed and extent of this progression are highly unpredictable. For some people, the condition is limited to small patches, and treatments can bring about remission within weeks or months [7]. For others, the disease can be more stubborn, causing temporary improvements followed by repeated relapses and a slower, more extensive spread over years [7][8].
In one large observational study, over half of the treated patients eventually achieved complete remission (a state where disease activity is halted, though it is not a permanent cure) [8]. However, reported rates vary by study and treatment, and studies also note that relapses frequently occur once treatments are stopped or reduced [8][3]. Managing FD is often a long-term commitment that requires ongoing monitoring even during quiet periods.
Factors That May Influence Prognosis
While every individual’s experience is unique, observational studies have identified a few associations that may influence how severe the condition becomes or how it might respond to treatment. These are general study findings, not reliable rules that predict your specific outcome:
- Age of onset: Some studies have associated developing the condition before age 25 with more severe disease and a lower likelihood of achieving quick, lasting remission [6][8][1].
- Bacterial presence: A positive bacterial culture (a lab test to identify bacteria) for Staphylococcus aureus during active flares has been associated with a more severe course in some cohorts [8]. However, S. aureus may just be naturally living on the skin (colonization) rather than directly causing the infection. A culture result alone does not establish infection, nor does it automatically mean you need antibiotics [8].
- Other health conditions: Having a co-existing inflammatory condition like hidradenitis suppurativa (a chronic skin condition causing painful lumps) has been linked to a more severe course of FD [8].
- Lesion characteristics: Having pustules specifically located within the bald patch, rather than just at the edges, has been associated with more severe cases in some research [6].
Monitoring Your Progress
Because the condition can flare up unpredictably, tracking the disease is crucial for protecting your remaining, viable hair follicles. Clinicians use several methods to monitor progression:
- Symptom tracking: Noting changes in pain, tenderness, and visible signs like new pustules, redness, and heavy crusts [6].
- Serial photography: Taking standardized photos of the scalp over time—using the same lighting, angle, and hair parting—provides an objective way to see if the scarred area is stable or expanding [1].
- Measuring patches: Clinicians may document the dimensions of bald patches, take photographs, or use validated activity-severity tools [6][1]. No single measurement determines severity on its own.
- Trichoscopy: This is a non-invasive magnifying tool dermatologists use to look closely at the scalp. It helps differentiate between active inflammation (such as subtle redness around the follicles, pustules, or crusting) and permanent scarring (such as loss of follicular openings or smooth, white scarred skin). Tufted hairs (multiple hairs emerging from a single pore) are a common feature of FD, but they can persist even when the inflammation is quiet, so your dermatologist will interpret the overall pattern [9][10].
What to Do During a Flare
If you notice warning signs of a flare—such as rapidly worsening pain, new pustules, heavy drainage, or expanding redness—contact your care team.
- Do not squeeze or pick at the pustules.
- Do not self-start leftover antibiotics.
- Do not stop or reduce (taper) your current prescribed medications on your own. Always follow the specific plan made with your dermatologist, as sudden changes can trigger a relapse.
Common questions in this guide
Does folliculitis decalvans always get worse over time?
Is hair loss from folliculitis decalvans permanent?
What are the warning signs of a folliculitis decalvans flare?
What factors can affect my folliculitis decalvans prognosis?
How do doctors monitor whether folliculitis decalvans is progressing?
Can folliculitis decalvans go into remission?
Related questions
Show more
Get notified when new evidence is published on Quinquaud folliculitis decalvans.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (10)
- 1
Folliculitis decalvans: Effectiveness of therapies and prognostic factors in a multicenter series of 60 patients with long-term follow-up.
Miguel-Gómez L, Rodrigues-Barata AR, Molina-Ruiz A, et al.
Journal of the American Academy of Dermatology 2018; (79(5)):878-883 doi:10.1016/j.jaad.2018.05.1240.
PMID: 29864465 - 2
Management of folliculitis decalvans: The EADV task force on hair diseases position statement.
Waśkiel-Burnat A, Starace M, Iorizzo M, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV 2025; (39(8)):1385-1394 doi:10.1111/jdv.20687.
PMID: 40230058 - 3
Navigating Treatments in Folliculitis Decalvans: A Comprehensive Systematic Review.
Al-Naesan I, Trafoier T, Krepper D, et al.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2026; doi:10.1111/ddg.70607.
PMID: 42750403 - 4
Successful Treatment with Fusidic Acid in a Patient with Folliculitis Decalvans.
Pimenta R, Borges-Costa J
Acta dermatovenerologica Croatica : ADC 2019; (27(1)):49-50.
PMID: 31032795 - 5
A Systematic Review of the Outcome of Hair Transplantation in Primary Scarring Alopecia.
Ekelem C, Pham C, Atanaskova Mesinkovska N
Skin appendage disorders 2019; (5(2)):65-71 doi:10.1159/000492539.
PMID: 30815438 - 6
Folliculitis decalvans: a multicentre review of 82 patients.
Vañó-Galván S, Molina-Ruiz AM, Fernández-Crehuet P, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV 2015; (29(9)):1750-7 doi:10.1111/jdv.12993.
PMID: 25682915 - 7
Retrospective Review of Folliculitis Decalvans in 23 Patients with Course and Treatment Analysis of Long-standing Cases.
Bunagan MJ, Banka N, Shapiro J
Journal of cutaneous medicine and surgery 2014; (18(5)):1-5.
PMID: 25277850 - 8
Diagnostic delay, comorbid hidradenitis suppurativa and the prognostic value of bacterial culture in folliculitis decalvans: A cohort study.
Lyakhovitsky A, Segal O, Galili E, et al.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2023; (21(12)):1469-1477 doi:10.1111/ddg.15202.
PMID: 37875786 - 9
Histopathologic and dermoscopic features of 42 cases of folliculitis decalvans: A case series.
Uchiyama M, Harada K, Tobita R, et al.
Journal of the American Academy of Dermatology 2021; (85(5)):1185-1193 doi:10.1016/j.jaad.2020.03.092.
PMID: 32272176 - 10
Non-invasive Assessment and Management of Folliculitis Decalvans by Trichoscopy and Reflectance Confocal Microscopy.
Piscazzi F, Franceschini C, Narcisi A, et al.
Dermatology practical & conceptual 2024; (14(3)) doi:10.5826/dpc.1403a167.
PMID: 39122540
This page explains the expected course of Quinquaud folliculitis decalvans for informational purposes only and is not medical advice. Your dermatologist should interpret your symptoms, monitoring results, and treatment plan.